App-Quantinova.ai

RO/SSA AUTOANTIBODIES IN A COHORT OF 552 SCLERODERMA PATIENTS

E. Zanatta - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Heart muscle disease

N/A

RETROSPECTIVE STUDY OF MULTITARGET THERAPY WITH COMBINATION OF MIZORIBINE AND TACROLIMUS FOR SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT NEPHRITIS

Y. Kukida - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

Biaxin

CARDIAC INVOLVEMENT IN ANKYLOSING SPONDYLITIS IN A TUNISIEN POPULATION

F. Ajili - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Heart muscle disease

N/A

IL-6 SERUM LEVELS AND CORONARY MICROVASCULAR DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS

E. Pigatto - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Heart muscle disease

ILS-969

PROBLEMS IN CONVENTIONAL THERAPY IN OSTEOARTHRITIS: A CASE PRESENTATION

W.Y. Kwok - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

SUCCESSFUL TOTAL HIP ARTHROPLASTY IN PATIENTS WITH SEVERE ANCA- ASSOCIATED VASCULITIS: SINGLE- CENTER EXPERIENCE

T.V. Beketova - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Rituximab

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AS A SCREENING TOOL IN PATIENTS WITH SUSPECTED VASCULITIS

A. Floris - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

N/A

Identification of at Risk Patients for Cardiac MRI Determined Sub-Clinical SSC-Cardiomyopathy (CM)

L.-A. Bissell - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

Cyclophosphamide

Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system

Peter M Izmirly - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Transfusional Iron Overload In An Adult Sickle Cell Disease Population: Epidemiology, Prevalence, and Management

James Son - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

Deferasirox

CMR Survey In a Large Cohort Of TI Patients

Antonella Meloni - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Grzegorz W. Basak - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Cyclosporine A

Adverse Pregnancy Outcomes In High Risk Sickle Cell Women

Pankhoori Saraf - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Heart muscle disease

Hydroxyurea

CARDIAC CINE MRI IN ERDHEIM-CHESTER DISEASE: DATA FROM A LARGE ITALIAN COHORT

C. Campochiaro - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Methadone hydrochloride

PLEUROPERICARDIAL EFFUSION, A RARE PRESENTING FEATURE IN PATIENTS WITH SARCOIDOSIS A CASE SERIES

C. Dharmapalaiah - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

N/A

SUBCLINICAL HEART INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS: A CONTROLLED STUDY

C. Papagoras - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Heart muscle disease

N/A

USE AND REASONS FOR NON-USE OF ANTIMALARIAL DRUGS IN A DUTCH COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

M. W.P. Tsang-A-Sjoe - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Hydroxychloroquine

EFFICACY AND SAFETY OF A COMBINED TREATMENT PROTOCOL FOR 2ND DEGREE CONGENITAL HEART BLOCK

A. Hoxha - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Betamethasone

HEART INVOLVEMENT IN SCLERODERMA PATIENTS AND MICE MODELS

P. Venalis - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

N/A

NEONATAL LUPUS ERYTHEMATOSUS AND ISOLATED CONGENITAL HEART BLOCK

Z. Mustapic - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Dexamethasone

Filters

3340 Abstracts